Company / Interest Expense
Amgen Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$2.8B
FY2025
5-year range
$1.2B / $3.2B
FY2021-FY2025
Trend
-12.7%
vs FY2024
Sector context
#2 of 42
Health Care
What the data says
Among 42 Health Care companies, Amgen is in the bottom 5% for interest expense. Interest Expense has fluctuated over the past 10 years, ranging from $1.2B in FY2021 to $3.2B in FY2024.
Based on SEC 10-K filings.
$2.8B in FY2025 with a 5-year CAGR of +16.9%. Ranks 2nd among 42 companies in Health Care.
Improved from $2.9B to $2.8B over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +25.1%
- 5-Year CAGR
- +16.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 42This company $2.8B Sector average $305.3M
▼
+802.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +16.9%, indicating consistent growth.
- In FY2025, interest expense decreased 12.7% year-over-year.
- Ranks #2 out of 42 companies in the Health Care sector.
- Peak interest expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.8B | -12.7% |
| FY2024 | $3.2B | +9.7% |
| FY2023 | $2.9B | +104.5% |
| FY2022 | $1.4B | +17.5% |
| FY2021 | $1.2B | -5.2% |
| FY2020 | $1.3B | -2.1% |
| FY2019 | $1.3B | -7.4% |
| FY2018 | $1.4B | +6.7% |
| FY2017 | $1.3B | +3.5% |
| FY2016 | $1.3B | +15.1% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026